In the United States, despite rising healthcare costs, life expectancy remains relatively stagnant, prompting a critical evaluation of the industry's financial landscape. Deloitte's outlook for 2024 underscores persistent financial challenges in the health care and life sciences sectors, including elevated capital costs, supply chain vulnerabilities, labor shortages, and escalating expenses. The report emphasizes the need for industry transformation and outlines As the health care and life sciences industries grapple with challenges, Deloitte envisions 2024 as a transitional year, urging organizations to sow the seeds of innovation and transformation to navigate a complex landscape and foster growth. The report suggests that breakthroughs in data sciences, coupled with efforts in interoperability and transparency, could lead to policy changes, emphasizing the industry's ongoing evolution towards data-driven solutions.
